Clinical trials
Phase 1 Glioma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
420 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 7 |
| 2002 | 5 |
| 2003 | 3 |
| 2004 | 5 |
| 2005 | 14 |
| 2006 | 7 |
| 2007 | 10 |
| 2008 | 10 |
| 2009 | 11 |
| 2010 | 19 |
| 2011 | 10 |
| 2012 | 18 |
| 2013 | 11 |
| 2014 | 20 |
| 2015 | 19 |
| 2016 | 14 |
| 2017 | 16 |
| 2018 | 26 |
| 2019 | 18 |
| 2020 | 19 |
| 2021 | 19 |
| 2022 | 16 |
| 2023 | 23 |
| 2024 | 21 |
| 2025 | 23 |
| 2026 | 29 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 192 |
| Recruiting | 66 |
| Terminated | 55 |
| Active, not recruiting | 39 |
| Unknown status | 26 |
| Not yet recruiting | 20 |
| Withdrawn | 18 |
| Suspended | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 27 |
| Duke University | 15 |
| City of Hope Medical Center | 13 |
| M.D. Anderson Cancer Center | 10 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 10 |
| Mayo Clinic | 7 |
| Nader Sanai | 7 |
| Annick Desjardins | 6 |
| Case Comprehensive Cancer Center | 6 |
| Memorial Sloan Kettering Cancer Center | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioma | 420 |
| Glioblastoma | 213 |
| Brain Neoplasms | 166 |
| Astrocytoma | 135 |
| Oligodendroglioma | 100 |
| Gliosarcoma | 86 |
| Central Nervous System Neoplasms | 57 |
| Ependymoma | 57 |
| Medulloblastoma | 45 |
| Diffuse Intrinsic Pontine Glioma | 32 |
Trials
Showing 51 to 75 of 420. Each trial links to its page on Pharma Observatory.
320 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.